<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01422057</url>
  </required_header>
  <id_info>
    <org_study_id>402/2009BO2-2</org_study_id>
    <nct_id>NCT01422057</nct_id>
  </id_info>
  <brief_title>Risk Prediction in Type II Diabetics With Ischemic Heart Disease</brief_title>
  <official_title>Risk Prediction in Type II Diabetics With Ischemic Heart Disease by Cardiac Autonomic Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thebiosignals.com</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thebiosignals.com</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test whether cardiac autonomic dysfunction predicts is a
      prognostic marker in type-2 diabetics with ischemic heart disease
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients with type 2-diabetes and ischemic heart disease autonomic function might be
      seriously affected.

      In the present study, markers of cardiac autonomic dysfunction, repolarization and
      respiration abnormalities will be assessed from Holter recordings and 30-minute recordings of
      high-resolution three dimensional ECG, non-invasive arterial blood pressure and respiratory
      activity.

      The correlation between markers of cardiac autonomic dysfunction and markers of severity of
      type-2 diabetes will be assessed. Autonomic dysfunction is assumed present when both heart
      rate turbulence and deceleration capacity are abnormal (&quot;severe autonomic failure&quot;).
      Assessment of severity of diabetes includes levels of HbA1c and urine albumine, duration and
      treatment of diabetes, and diabetes related complications (nephropathy, neuropathy,
      retinopathy).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major cardiovascular event</measure>
    <time_frame>2 years</time_frame>
    <description>Combination of total mortality, non-fatal myocardial infarction and non-fatal stroke</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sudden cardiac death</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total mortality</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Type-2 Diabetes Mellitus</condition>
  <condition>Ischemic Heart Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients with diagnose of ischemic heart disease and type-2 diabetes are
        included.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type-2 diabetes

          -  coronary artery disease

        Exclusion Criteria:

          -  age &gt;80 years

          -  acute coronary syndrome

          -  life expectancy &lt;1 year

          -  unable to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christine Zürn, MD</last_name>
    <phone>+49 7071 29 83153</phone>
    <email>christine.zuern@med.uni-tuebingen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiology</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Zürn, MD</last_name>
      <phone>+49 7071 29 83153</phone>
      <email>christine.zuern@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Axel Bauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2011</study_first_submitted>
  <study_first_submitted_qc>August 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2011</study_first_posted>
  <last_update_submitted>February 5, 2014</last_update_submitted>
  <last_update_submitted_qc>February 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Thebiosignals.com</investigator_affiliation>
    <investigator_full_name>Axel Bauer</investigator_full_name>
    <investigator_title>Prof. Dr. med. Axel Bauer</investigator_title>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>coronary artery disease</keyword>
  <keyword>ischemic heart disease</keyword>
  <keyword>autonomic function</keyword>
  <keyword>heart rate turbulence</keyword>
  <keyword>deceleration capacity</keyword>
  <keyword>severe autonomic failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

